Equibles does not estimate personal net worth.
Get an email with a short summary when Boston Scientific Corp publishes a filing, an earnings call transcript or a press release.
Get BSX alertsMichael Mahoney is recorded as CEO at Boston Scientific Corp (BSX). The newest filing on record that lists Michael Mahoney as CEO at Boston Scientific Corp (BSX) is dated March 24, 2021. The proxy statement of Boston Scientific Corp reports total compensation of $23,532,050 for Michael Mahoney in fiscal 2025, including a base salary of $1,442,603. Disclosed compensation is on record for 9 fiscal years. Michael Mahoney has spoken on 12 earnings calls across 1 company, most recently for Boston Scientific Corp on October 28, 2026. Boston Scientific Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Boston Scientific Corp includes Jonathan Monson (CFO), Joe Fitzgerald (COO), Jodi Euerle Eddy (CIO) and 7 others.
“I want to begin by walking through our third quarter results, provide some fourth quarter outlook, and then assumptions behind our updated view of 2027. I'll then provide more details on both the region and business unit performance and outlook.”
“First quarter represented a solid quarter for Boston Scientific with total company organic sales growth of 9.4% versus our guidance range of 8.5% to 10%. First quarter adjusted EPS of 80 cents through 6% achieving a high number guidance range of $0.78 to $0.80, and Q1 adjusted operating margin was $0.28.”
“Our quarterly results again exceeded our expectations led by our innovative portfolio, strong execution and a winning spirit of our global team.”
“Our second quarter results outperformed our expectations, led by our Cardiovascular segment closing a phenomenal first half of 2025.”
“In Q1, we delivered excellent results, all while we continue to invest in our highly innovative portfolio and capabilities.”
Start not stated–present
Last confirmed March 24, 2021
Medical Devices · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,442,603 | $23,532,050 |
| 2024 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,400,000 | $21,420,801 |
| 2023 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,400,000 | $18,723,735 |
| 2022 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,395,178 | $16,941,961 |
| 2021 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,344,329 | $16,064,039 |
| 2020 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $666,878 | $13,773,795 |
| 2019 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,274,740 | $15,764,140 |
| 2018 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,234,630 | $13,970,901 |
| 2017 | Boston Scientific Corp (BSX) | Chairman of the Board, President and Chief Executive Officer | $1,179,452 | $13,084,452 |
